16 companies

Madrigal Pharmaceuticals

Market Cap: US$10.6b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$518.76

7D

14.2%

1Y

53.8%

Ascendis Pharma

Market Cap: US$13.6b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

ASND

US$220.60

7D

-1.4%

1Y

39.7%

Insmed

Market Cap: US$32.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

INSM

US$147.60

7D

2.5%

1Y

90.0%

Alnylam Pharmaceuticals

Market Cap: US$43.6b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

ALNY

US$328.16

7D

5.5%

1Y

21.1%

BridgeBio Pharma

Market Cap: US$13.9b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.

BBIO

US$72.58

7D

3.6%

1Y

99.4%

BeOne Medicines

Market Cap: US$31.4b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$276.95

7D

-2.0%

1Y

5.5%

Ionis Pharmaceuticals

Market Cap: US$12.0b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

IONS

US$74.24

7D

4.1%

1Y

134.0%

AbbVie

Market Cap: US$366.5b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

ABBV

US$211.12

7D

2.4%

1Y

4.1%

Jazz Pharmaceuticals

Market Cap: US$11.6b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

JAZZ

US$189.15

7D

4.0%

1Y

49.6%

Eli Lilly

Market Cap: US$819.9b

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

LLY

US$897.00

7D

-2.2%

1Y

9.2%

BioMarin Pharmaceutical

Market Cap: US$10.7b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

BMRN

US$55.55

7D

0.9%

1Y

-23.7%

Natera

Market Cap: US$28.0b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

NTRA

US$196.15

7D

-3.2%

1Y

32.3%

Royalty Pharma

Market Cap: US$27.1b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

RPRX

US$46.94

7D

3.1%

1Y

48.3%

Viatris

Market Cap: US$15.5b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS

US$13.37

7D

-1.0%

1Y

51.2%

Elanco Animal Health

Market Cap: US$12.7b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$24.58

7D

-2.1%

1Y

127.4%

Waters

Market Cap: US$29.7b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

WAT

US$300.56

7D

0.3%

1Y

-18.9%